期刊文献+

保留改良尿管联合经尿道前列腺切除术治疗晚期前列腺癌出血合并膀胱填塞的临床疗效

Clinical efficacy of preserving modified urinary catheter combined with transurethral prostatectomy in the treatment of advanced prostate cancer hemorrhage with bladder tamponade
下载PDF
导出
摘要 目的探讨保留改良尿管联合经尿道前列腺切除术治疗晚期前列腺癌出血合并膀胱填塞的疗效。方法选取2016年1月至2020年10月本院收治的106例晚期前列腺癌出血合并膀胱填塞患者作为研究对象,采用随机数字表法分为对照组(n=50)与观察组(n=56)。对照组采用常规导尿联合经尿道前列腺切除术,观察组在对照组基础上于术后应用保留改良尿管,比较两组术前、术后2个月国际前列腺症状评分(IPSS)、生命质量评分(QOL)及术后3 d内膀胱痉挛率、术后导尿管堵塞率、更换尿管率、术后膀胱持续冲洗引流液颜色变淡时间、拔管时间。结果术后2个月,两组IPSS、QOL评分均低于术前,且观察组IPSS评分低于对照组,差异有统计学意义(P<0.05),但两组QOL评分比较差异无统计学意义。观察组术后3 d内膀胱痉挛率、术后导尿管堵塞率、更换尿管率均低于对照组,差异有统计学意义(P<0.05)。观察组术后膀胱持续冲洗引流液颜色变淡时间、拔管时间短于对照组,差异有统计学意义(P<0.05)。结论经尿道前列腺切除术能姑息性治疗晚期前列腺癌出血合并膀胱填塞,联合术后保留改良导尿管可减轻患者下尿路症状,降低术后并发症发生率,有助于促进患者尽快康复。 Objective To explore the efficacy of preserving modified urinary catheter combined with transurethral prostatectomy in the treatment of advanced prostate cancer hemorrhage with bladder tamponade.Methods 106 patients with advanced prostate cancer hemorrhage with bladder tamponade admitted to our hospital from January 2016 to October 2020 were selected as the research subjects,and they were divided into the control group(n=50)and the observation group(n=56)according to the random number table method.The control group received conventional catheterization combined with transurethral prostatectomy,and the observation group received modified urethral catheter after surgery on the basis of the control group,the international prostatic symptom score(IPSS),quality of life(QOL)score before and 2 months after surgery,and the bladder spasm rate within 3 d after surgery,postoperative catheter blockage rate,catheter replacement rate,postoperative continuous bladder irrigation and drainage fluid color fading time,and extubation time were compared between the two groups.Results 2 months after surgery,the IPSS and QOL scores of the two groups were lower than those before surgery,and the IPSS score in the observation group was lower than that in the control group,the differences were statistically significant(P<0.05),but there was no statistically significant difference in QOL score between the two groups.The rate of bladder spasm within 3 d after surgery,the rate of postoperative catheter blockage and the rate of catheter replacement in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The postoperative continuous bladder irrigation and drainage fluid color fading time,and extubation time in the observation group were shorter than those in the control group,and the differences were statistically significant(P<0.05).Conclusion Transurethral prostatectomy can palliative treatment for advanced prostate cancer hemorrhage,combined with postoperative preserving modified urinary catheter can can alleviate the lower urinary tract symptoms of patients,reduce the incidence of postoperative complications,and help to promote the speedy recovery of patients.
作者 罗波 蔡珂 辛娜娜 孙媛 张帅 张劲峰 刘鹏 LUO Bo;CAI Ke;XIN Na'na;SUN Yuan;ZHANG Shuai;ZHANG Jinfeng;LIU Peng(Department of Urology,Songshan Hospital,Qingdao University Medical College,Qingdao,Shandong,266021,China;Department of General Practice,Songshan Hospital,Qingdao University Medical College,Qingdao,Shandong,266021,China;Department of Medicine,Songshan Hospital,Qingdao University Medical College,Qingdao,Shandong,266021,China)
出处 《当代医学》 2023年第19期73-77,共5页 Contemporary Medicine
关键词 前列腺癌 前列腺电切术 出血 导尿 膀胱填塞 Prostate cancer Electroprostatectomy Prostatectomy Hemorrhage Urethral catheterization Bladder tamponade
  • 相关文献

参考文献9

二级参考文献60

  • 1沈华锋,郑祥毅,谢立平.膀胱过度活动症的治疗进展[J].国外医学(泌尿系统分册),2005,25(1):42-46. 被引量:18
  • 2赵军,贺大林,刘润明,王明珠,王小宁,邢俊平,南勋义.良性前列腺增生相关的膀胱痉挛病因分析及治疗[J].中华男科学杂志,2005,11(4):275-277. 被引量:44
  • 3唐国民,廖洪,张荣荣.18例中晚期前列腺癌治疗的疗效分析[J].四川肿瘤防治,2006,19(3):180-181. 被引量:1
  • 4Hashim H, Paul A. Drug treatment of overactive bladder. Drugs, 2004, 64 (15) : 1643-1656.
  • 5Milsim SI, Abrams P, Cardozo L, et al. How widespread are the symptoms ofan overactive bladderand how are theymanaged? A pop- ula-tion-based prevalence study. Br JUml Int, 2001,87 : 760-766.
  • 6Sah ML, Saini TR. Formulation development and release studies of indomethacin suppositories. Indian J Pharm Sci, 2008,70 ( 4 ) : 498-501.
  • 7Lepor H, Tang R, Shapiro E. The alpha adrenoceptor subtype mediating the tension of human prostatic smooth muscle. Prostate, 1993, 22: 301- 307.
  • 8ChungM, Vashi V, Puente J, et al. Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system ( GITS ) formulation. Br J Clin Pharmacol, 48 : 678-687.
  • 9Sivrikaya A, Celik OF, Sivrikaya N, et al. The effect of diclofenac sodium and papaverine on isolated human ureteric smooth muscle. Urol Nephrol, 2003, 35 : 479-483.
  • 10马春光,叶定伟,李长岭,周芳坚,姚旭东,张世林,戴波,张海梁,朱耀,沈益君.前列腺癌的流行病学特征及晚期一线内分泌治疗分析[J].中华外科杂志,2008,46(12):921-925. 被引量:120

共引文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部